Participants will be able to develop a comprehensive understanding of treatment sequencing strategies in patients with metastatic breast cancer; gain in-depth insight into the biological mechanisms underlying metastatic breast cancer; enhance knowledge of the safety profiles and management of adverse events associated with targeted therapies; recognise the critical role of a multidisciplinary approach in optimising outcomes for patients with metastatic breast cancer.